The first report to address long-term outcomes for patients with severe native mitral regurgitation (MR) who are treated with transcatheter mitral valve replacement has found that post-procedural reductions in MR held up over time, with no significant recurrence upon two-year follow-up.

Excess greater left ventricle (LV) trabeculation is associated with decreased average regional myocardial function, measured by myocardial strain. A team of researchers, examining MRIs of 1,123 individuals, found that average regional LV function was worse in those with greater LV trabeculation.

A multidisciplinary team of experts has released a joint consensus document on the role of F-FDG PET/CT in cardiac sarcoid detection and therapy monitoring.

WESTLAKE, Texas, Aug. 17, 2017 — HeartSciences today announced the European launch of MyoVista® high sensitivity electrocardiograph (hsECG™) Testing Device, developed in response to the global unmet need for effective, low-cost, front-line screening of cardiac disease in both symptomatic and asymptomatic patients.

Computed tomography (CT)-derived measures of annulus area can be used to flag cases of heightened risk for poor hemodynamics after valve-in-valve (VIV) procedures, according to recently published research.

New research published online in the Journal of the American College of Radiology examined whether the updated USPSTF guidelines have affected AAA ultrasound screenings in terms of volume and patient diversity.

AUM Cardiovascular has received clearance from the U.S. Food and Drug Administration (FDA) for its acoustic and ECG device to detect heart murmurs.

The Department of Homeland Security (DHS) and Siemens Healthineers issued an advisory that four of the company’s diagnostic imaging systems may be vulnerable to cyberattacks.